SCHEDULE 13G

Company

GT Biopharma, Inc.

Filed

September 19, 2023

Accession Number

0001042167-23-000059

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →